Your browser doesn't support javascript.
loading
Gemcitabine and bendamustine is a safe and effective salvage regimen for patients with recurrent/refractory Hodgkin lymphoma: Results of a phase 1/2 study.
Cohen, Jonathon B; Wei, Lai; Maddocks, Kami J; Christian, Beth; Heffner, Leonard T; Langston, Amelia A; Lechowicz, Mary Jo; Porcu, Pierluigi; Flowers, Christopher R; Devine, Steven M; Blum, Kristie A.
Afiliação
  • Cohen JB; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia.
  • Wei L; Center for Biostatistics, The Ohio State University, Columbus, Ohio.
  • Maddocks KJ; Division of Hematology, James Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio.
  • Christian B; Division of Hematology, James Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio.
  • Heffner LT; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia.
  • Langston AA; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia.
  • Lechowicz MJ; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia.
  • Porcu P; Division of Hematology, James Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio.
  • Flowers CR; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia.
  • Devine SM; Division of Hematology, James Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio.
  • Blum KA; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia.
Cancer ; 126(6): 1235-1242, 2020 03 15.
Article em En | MEDLINE | ID: mdl-31821549
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Hodgkin / Protocolos de Quimioterapia Combinada Antineoplásica / Terapia de Salvação / Desoxicitidina / Cloridrato de Bendamustina Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Geórgia
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Hodgkin / Protocolos de Quimioterapia Combinada Antineoplásica / Terapia de Salvação / Desoxicitidina / Cloridrato de Bendamustina Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Geórgia